Our Mission
Our mission is to create mRNA lipid nanoparticle based treatments for patients afflicted by diseases that are caused by the elimination of a particular human protein. Our responsibility as a pharmaceutical company is to improve the quality of human life by reversing medical conditions caused by genetic abnormalities and mutations.
Our Motivation
Our President and CEO's grandmother fondly referred to as "Grannan", passed away in September of 2018, from neuroblastoma cancer and inspired the name Grann Pharmaceuticals. Our commitment to enhancing the quality of human life is motivated by her legacy.
Meet the CEO
Meet the CEO
Thomas Lyle Temple
Inspired by the resilience and legacy of my grandmother, Grannan, who lost her battle with neuroblastoma cancer in 2018, I founded Grann Pharmaceuticals with a mission to improve the quality of human life. Our work focuses on the development of mRNA lipid nanoparticle-based treatments, aiming to reverse medical conditions caused by genetic abnormalities and mutations. Driven by cutting-edge nanotechnology, our goal is to create innovative solutions for diseases, ensuring that our advancements have a profound and positive impact on the lives of patients worldwide.
CONTACT US
CONTACT US
Contact Us!
For general inquiries or partnership opportunities.